157 related articles for article (PubMed ID: 2870532)
1. The modulation of head-twitch behaviour by drugs acting on beta-adrenoceptors: evidence for the involvement of both beta 1- and beta 2-adrenoceptors.
Handley SL; Singh L
Psychopharmacology (Berl); 1986; 88(3):320-4. PubMed ID: 2870532
[TBL] [Abstract][Full Text] [Related]
2. Chronic antidepressant treatment reduces central beta-adrenoceptor sensitivity in a behavioural test.
Handley SL; Singh L
Eur J Pharmacol; 1986 Aug; 127(1-2):97-103. PubMed ID: 3019728
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the existence of postsynaptic beta-1 and beta-2 adrenoceptors in isolated simian facial veins.
Chiba S; Tsukada M
Heart Vessels; 1991; 6(3):168-74. PubMed ID: 1680847
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the locus coeruleus in the potentiation of the quipazine-induced head-twitch response by diazepam and beta-adrenoceptor agonists.
Handley SL; Singh L
Neuropharmacology; 1986 Dec; 25(12):1315-21. PubMed ID: 2882436
[TBL] [Abstract][Full Text] [Related]
6. Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.
Hallberg H
Br J Pharmacol; 1986 Feb; 87(2):403-8. PubMed ID: 2869814
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the effects of stimulation or blockade of beta-adrenoceptors on the head-twitches induced in mice by 5-hydroxytryptophan versus 5-methoxy-N, N-dimethyltryptamine.
Martin P; Soubrié P; Simon P
J Pharmacol; 1986; 17(2):119-25. PubMed ID: 2875219
[TBL] [Abstract][Full Text] [Related]
9. Involvement of noradrenaline in potentiation of the head-twitch response by GABA-related drugs.
Singh L; Heaton JC; Rea PJ; Handley SL
Psychopharmacology (Berl); 1986; 88(3):315-9. PubMed ID: 2870531
[TBL] [Abstract][Full Text] [Related]
10. Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.
Zerkowski HR; Ikezono K; Rohm N; Reidemeister JC; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):142-7. PubMed ID: 2871495
[TBL] [Abstract][Full Text] [Related]
11. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
12. Characterization of beta-adrenoceptors in the dog saphenous vein.
Tokudome T; Taira N
Jpn J Pharmacol; 1981 Oct; 31(5):731-6. PubMed ID: 6118453
[TBL] [Abstract][Full Text] [Related]
13. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
14. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
15. Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice.
Criscuoli M; Subissi A
Br J Pharmacol; 1988 Jan; 93(1):132-8. PubMed ID: 2894872
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection.
Junker V; Becker A; Hühne R; Zembatov M; Ravati A; Culmsee C; Krieglstein J
Eur J Pharmacol; 2002 Jun; 446(1-3):25-36. PubMed ID: 12098582
[TBL] [Abstract][Full Text] [Related]
17. Beta adrenoceptors in the canine large coronary arteries: beta-1 adrenoceptors predominate in vasodilation.
Nakane T; Tsujimoto G; Hashimoto K; Chiba S
J Pharmacol Exp Ther; 1988 Jun; 245(3):936-43. PubMed ID: 2898525
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.
Ek BA; Bjellin LA; Lundgren BT
Gastroenterology; 1986 Feb; 90(2):400-7. PubMed ID: 2867001
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
20. Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.
Brodde OE; Daul A; Michel MC
Clin Physiol Biochem; 1990; 8 Suppl 2():11-7. PubMed ID: 1982757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
